Page last updated: 2024-11-12

sm360320

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

SM360320: Proc Natl Acad Sci U S A 2006 Feb 7;103(6):1828-33 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10018576
CHEMBL ID210884
SCHEMBL ID43700
MeSH IDM0496246

Synonyms (35)

Synonym
9-benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine
6-amino-9-benzyl-2-(2-methoxyethoxy)-9h-purin-8-ol
tlr7 ligand ii
6-amino-9-benzyl-2-(2-methoxyethoxy)-7h-purin-8(9h)-one
bdbm50189516
9-benzyl-2-methoxyethoxy-8-oxoadenine
9-benzyl-2-(2-methoxyethoxy)-8-oxoadenine
sm-360320
CHEMBL210884 ,
226907-52-4
BCP9000189
AKOS015995219
toll-like receptor 7 ligand ii
6-amino-7,9-dihydro-2-(2-methoxyethoxy)-9-(phenylmethyl)-8h-purin-8-one
SCHEMBL43700
6-amino-9-benzyl-8-hydroxy-2-(2-methoxyethoxy)purine
YYCDGEZXHXHLGW-UHFFFAOYSA-N
6-amino-9-benzyl-2-(2-methoxy-ethoxy)-9h-purin-8-ol
DTXSID60434307
J-014813
9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine
sm360320
BCP26295
A846167
ewu ,
6-azanyl-2-(2-methoxyethoxy)-9-(phenylmethyl)-7h-purin-8-one
MS-24631
SB83244
EX-A6678
6-amino-9-benzyl-2-(2-methoxyethoxy)-7h-purin-8-one
BJA90752
HY-125390
CS-0091069
cl-087
AKOS040744411

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dosing whole rats repeatedly with different concentrations of SM360320 confirmed the in vitro results."( Comparison of rat and human responses to toll-like receptor 7 activation.
Clarke, S; Horscroft, N; Laxton, C; Parkinson, T; Richard, V; Thomas, A, 2009
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)IC50 (µMol)2.80900.05201.20935.6000AID1679179
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Toll-like receptor 7Homo sapiens (human)EC50 (µMol)0.83780.00721.57446.8000AID1666732; AID1679178; AID474844
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Toll-like receptor 8Homo sapiens (human)ECmax (µMol)0.08000.08005.040010.0000AID1666737
Toll-like receptor 8Homo sapiens (human)MEC1.04000.08001.35173.6500AID1666737; AID1666739
Toll-like receptor 7Homo sapiens (human)ECmax (µMol)0.08000.08005.040010.0000AID1666737
Toll-like receptor 7Homo sapiens (human)MEC0.08000.00300.06570.1000AID1666737
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
purine nucleoside catabolic process7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
DNA repair7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
response to oxidative stress7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
male gonad development7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
DNA protection7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
response to cadmium ion7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
regulation of protein phosphorylationToll-like receptor 8Homo sapiens (human)
inflammatory responseToll-like receptor 8Homo sapiens (human)
response to virusToll-like receptor 8Homo sapiens (human)
immunoglobulin mediated immune responseToll-like receptor 8Homo sapiens (human)
negative regulation of interleukin-12 productionToll-like receptor 8Homo sapiens (human)
positive regulation of interferon-alpha productionToll-like receptor 8Homo sapiens (human)
positive regulation of interferon-beta productionToll-like receptor 8Homo sapiens (human)
positive regulation of type II interferon productionToll-like receptor 8Homo sapiens (human)
positive regulation of interleukin-1 beta productionToll-like receptor 8Homo sapiens (human)
positive regulation of interleukin-6 productionToll-like receptor 8Homo sapiens (human)
positive regulation of interleukin-8 productionToll-like receptor 8Homo sapiens (human)
toll-like receptor 8 signaling pathwayToll-like receptor 8Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionToll-like receptor 8Homo sapiens (human)
innate immune responseToll-like receptor 8Homo sapiens (human)
positive regulation of innate immune responseToll-like receptor 8Homo sapiens (human)
defense response to virusToll-like receptor 8Homo sapiens (human)
cellular response to mechanical stimulusToll-like receptor 8Homo sapiens (human)
toll-like receptor signaling pathwayToll-like receptor 8Homo sapiens (human)
canonical NF-kappaB signal transductionToll-like receptor 8Homo sapiens (human)
regulation of protein phosphorylationToll-like receptor 7Homo sapiens (human)
inflammatory responseToll-like receptor 7Homo sapiens (human)
canonical NF-kappaB signal transductionToll-like receptor 7Homo sapiens (human)
I-kappaB phosphorylationToll-like receptor 7Homo sapiens (human)
JNK cascadeToll-like receptor 7Homo sapiens (human)
positive regulation of chemokine productionToll-like receptor 7Homo sapiens (human)
positive regulation of interferon-alpha productionToll-like receptor 7Homo sapiens (human)
positive regulation of interferon-beta productionToll-like receptor 7Homo sapiens (human)
positive regulation of type II interferon productionToll-like receptor 7Homo sapiens (human)
positive regulation of interleukin-8 productionToll-like receptor 7Homo sapiens (human)
toll-like receptor 7 signaling pathwayToll-like receptor 7Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionToll-like receptor 7Homo sapiens (human)
innate immune responseToll-like receptor 7Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIToll-like receptor 7Homo sapiens (human)
positive regulation of inflammatory responseToll-like receptor 7Homo sapiens (human)
defense response to virusToll-like receptor 7Homo sapiens (human)
positive regulation of macrophage cytokine productionToll-like receptor 7Homo sapiens (human)
response to cGMPToll-like receptor 7Homo sapiens (human)
cellular response to mechanical stimulusToll-like receptor 7Homo sapiens (human)
cellular response to virusToll-like receptor 7Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionToll-like receptor 7Homo sapiens (human)
toll-like receptor signaling pathwayToll-like receptor 7Homo sapiens (human)
positive regulation of interleukin-6 productionToll-like receptor 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (20)

Processvia Protein(s)Taxonomy
5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
protein binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
dATP diphosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
snoRNA binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
metal ion binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
ATP diphosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
2-hydroxy-ATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
2-hydroxy-dATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
N6-methyl-(d)ATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
O6-methyl-dGTP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
DNA bindingToll-like receptor 8Homo sapiens (human)
RNA bindingToll-like receptor 8Homo sapiens (human)
double-stranded RNA bindingToll-like receptor 8Homo sapiens (human)
single-stranded RNA bindingToll-like receptor 8Homo sapiens (human)
signaling receptor activityToll-like receptor 8Homo sapiens (human)
pattern recognition receptor activityToll-like receptor 8Homo sapiens (human)
double-stranded RNA bindingToll-like receptor 7Homo sapiens (human)
single-stranded RNA bindingToll-like receptor 7Homo sapiens (human)
protein bindingToll-like receptor 7Homo sapiens (human)
siRNA bindingToll-like receptor 7Homo sapiens (human)
pattern recognition receptor activityToll-like receptor 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
acrosomal vesicle7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
extracellular space7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
nucleus7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytoplasm7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
mitochondrion7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
mitochondrial matrix7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytosol7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
nuclear membrane7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytoplasm7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
Golgi membraneToll-like receptor 8Homo sapiens (human)
endoplasmic reticulum membraneToll-like receptor 8Homo sapiens (human)
external side of plasma membraneToll-like receptor 8Homo sapiens (human)
endosome membraneToll-like receptor 8Homo sapiens (human)
endolysosome membraneToll-like receptor 8Homo sapiens (human)
plasma membraneToll-like receptor 8Homo sapiens (human)
Golgi membraneToll-like receptor 7Homo sapiens (human)
cytoplasmToll-like receptor 7Homo sapiens (human)
lysosomeToll-like receptor 7Homo sapiens (human)
endosomeToll-like receptor 7Homo sapiens (human)
endoplasmic reticulumToll-like receptor 7Homo sapiens (human)
endoplasmic reticulum membraneToll-like receptor 7Homo sapiens (human)
plasma membraneToll-like receptor 7Homo sapiens (human)
endosome membraneToll-like receptor 7Homo sapiens (human)
early phagosomeToll-like receptor 7Homo sapiens (human)
endolysosome membraneToll-like receptor 7Homo sapiens (human)
receptor complexToll-like receptor 7Homo sapiens (human)
plasma membraneToll-like receptor 7Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID341170Antiviral activity against HCV infected human Huh7 replicon cells assessed as viral levels by luciferase assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID509676Absorption rate constant for depot compartment in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID1666732Agonist activity at human TLR7 expressed in HEK293 cells assessed as induction of NFKappaB activity after 24 hrs by SEAP reporter gene assay2020Bioorganic & medicinal chemistry letters, 03-15, Volume: 30, Issue:6
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
AID270228Maximal IFNalpha production in human PBMC at 10 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and immunostimulatory activity of 8-substituted amino 9-benzyladenines as potent Toll-like receptor 7 agonists.
AID270227Induction of IFNalpha production in human PBMC2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and immunostimulatory activity of 8-substituted amino 9-benzyladenines as potent Toll-like receptor 7 agonists.
AID509679Induction of IFNalpha production in CD1 mouse assessed as elimination rate constant for interferon alpha at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID1666740Agonist activity at TLR8 in human PBMC assessed as TNFalpha level at 10 uM2020Bioorganic & medicinal chemistry letters, 03-15, Volume: 30, Issue:6
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
AID1666737Agonist activity at TLR7/TLR8 in human PBMC assessed as IFN alpha level2020Bioorganic & medicinal chemistry letters, 03-15, Volume: 30, Issue:6
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
AID509678Induction of IFNalpha production in CD1 mouse assessed as concentration of compound required for half-maximal synthesis of INF-alpha at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID474845Half life in human plasma by LS-MS analysis2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
AID509832Antiviral activity against HCV infected in human Huh7 cells with persistent PFK1389-Luc-Ubi-Neo-NS3-3'/ET replicon after 48 hrs by luminescence based assay2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID509830Apparent volume of distribution in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID1666739Agonist activity at TLR8 in human PBMC assessed as TNFalpha level2020Bioorganic & medicinal chemistry letters, 03-15, Volume: 30, Issue:6
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
AID509677Intercompartmental clearance in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID474844Agonist activity at human TLR7 expressed in HEK293 cells coexpressing pNiFty2-SEAP reporter by reporter gene assay2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
AID1645924Antiviral activity against HCV2019European journal of medicinal chemistry, Feb-15, Volume: 164A review on HCV inhibitors: Significance of non-structural polyproteins.
AID341160Induction of IFNalpha2a level in human PBMC assessed as drug level causing maximal cytokine induction after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID509675Volume of distribution in peripheral compartment in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID349531Induction of TLR7 receptor-mediated C57BL/6 mouse BMD cells activation assessed as upregulation of CD40 at 1 uM after 48 hrs by flow cytometry2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
AID341176Antiviral activity against HCV infected human Huh7 replicon cells treated with 200 nM drug-induced human PBMC supernatants assessed as viral levels in presence of type I IFN receptor antibody by luciferase assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID341161Toxic induction of IL6 level in human PBMC assessed as drug level causing maximal cytokine induction after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID509673Clearance in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID349532Induction of TLR7 receptor-mediated C57BL/6 mouse BMD cells activation assessed as IL12 production at 5 uM after 24 hrs by ELISA2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
AID509680Induction of IFNalpha production in CD1 mouse assessed as maximum rate of interferon alpha synthesis at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID509674Volume of distribution in central compartment in CD1 mouse at 0.1 to 10 mg/kg, po2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID509831Oral bioavailability in rat at 3 mg/kg2010Antimicrobial agents and chemotherapy, Mar, Volume: 54, Issue:3
Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
AID341159Toxic induction of IL1-beta level in human PBMC assessed as drug level causing maximal cytokine induction after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID341177Toxic induction of TNFalpha level in human PBMC assessed as drug level causing maximal cytokine induction after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID341171Increase in 2',5'-oligoadenylate synthase level in human PBMC after 24 hrs by PCR method relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID265527Induction of IL-12p40 in dendritic cells2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines.
AID341169Antiviral activity against HCV infected human Huh7 replicon cells treated with drug-induced human PBMC supernatants assessed as viral levels by luciferase assay2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID341172Increase in IFNalpha level in human PBMC after 24 hrs relative to control2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Investigating Toll-like receptor agonists for potential to treat hepatitis C virus infection.
AID270226Induction of IFNalpha production in human PBMC at 1 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Synthesis and immunostimulatory activity of 8-substituted amino 9-benzyladenines as potent Toll-like receptor 7 agonists.
AID1679178Agonist activity at TLR7 in human PBMC assessed as induction of IN-12 stimulation2016Journal of medicinal chemistry, Mar-24, Volume: 59, Issue:6
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
AID349529Induction of TLR7 receptor-mediated C57BL/6 mouse BMD cells activation assessed as upregulation of CD86 at 1 uM after 48 hrs by flow cytometry2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
AID1666738Agonist activity at TLR7 in human PBMC assessed as IFNalpha stimulation at 10 uM2020Bioorganic & medicinal chemistry letters, 03-15, Volume: 30, Issue:6
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
AID1679179Inhibition of MTH1 (unknown origin) using 8-oxo-dGTP as substrate preincubated for 15 mins followed by substrate addition and measured after 20 mins by PPiLight detection reagent based luminescence assay2016Journal of medicinal chemistry, Mar-24, Volume: 59, Issue:6
Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
AID349530Induction of TLR7 receptor-mediated C57BL/6 mouse BMD cells activation assessed as upregulation of MHC class-2 at 1 uM after 48 hrs by flow cytometry2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (55.56)29.6817
2010's7 (38.89)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.43 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]